Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Relapsing multiple sclerosis patients can look to second oral agent.
Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
Chronic Inflammatory Demyelinating Polyneuropathy Manifesting as Neuropathy With Liability to Pressure Palsies: A Case Report.
T-cell reactivity against AQP4 in neuromyelitis optica.
Status migrainosus as an initial presentation of multiple sclerosis.
The role of IL-17 in CNS diseases.
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Aerobic Fitness Is Associated with Inhibitory Control in Persons with Multiple Sclerosis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies.
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Benign-onset acute disseminated encephalomyelitis: a report on two cases.
DNase hypersensitive sites and association with multiple sclerosis.
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Factors associated with unemployment among persons with multiple sclerosis.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Clinical prospective study of visual function in patients with acute optic neuritis.
Multiple sclerosis: Managing patients in primary care.
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Pages
« first
‹ previous
…
388
389
390
391
392
393
394
395
396
…
next ›
last »